Quest Diagnostics Incorporated (DGX) Q2 2010 Earnings Results

Quest Diagnostics Beats on EPS, Stock Down 6.5%

Quest Diagnostics reported an EPS of $1.07, slightly beating expectations, but the stock fell by 6.5% in reaction. The decline may be attributed to broader market trends or concerns about future performance, as no revenue figures or guidance were provided.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.07	N/A	+0.75%
Revenue	N/A	N/A	—

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

Quest Diagnostics Beats on EPS, Stock Down 6.5%

Key numbers

Management commentary

Quest Diagnostics Incorporated

More earnings this week

Quest Diagnostics Beats on EPS, Stock Down 6.5%

Key numbers

Management commentary